Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 304
Selected: 0
NCT IDTitle
NCT04868227Scottish Vitamin D Intervention Study
NCT00757991Blood Samples From Healthy Volunteers for Genetic Studies in the East Anglia Region of the United Kingdom
NCT01881386Lactate Imaging as a Tumour Biomarker
NCT03096054A CR-UK Phase I Trial of LY3143921
NCT01263171Oxaliplatin, Leucovorin, and Fluorouracil Before and After Radiation Therapy and Surgery in Treating Patients With Rectal Cancer That Can Be Removed by Surgery
NCT05848765Relapsed Follicular Lymphoma Randomised Trial Against Standard ChemoTherapy
NCT02147028Hippocampal Sparing Whole Brain Radiotherapy vs Conventional Whole Brain Radiotherapy in Patients With Brain Metastases
NCT03562169The Role of Ixazomib in Autologous Stem Cell Transplant in Relapsed Myeloma - Myeloma XII (ACCoRd)
NCT01685190A Study of Prostate and pelvIs Versus prOsTate Alone Treatment for Locally Advanced Prostate Cancer
NCT05786716DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations
NCT03486730BT1718 in Patients with Advanced Solid Tumours.
NCT04717674[18F]FPIA PET/CT Imaging in Patients With Solid Tumours
NCT03934164Molecular Stratification Profiling Protocol in Metastatic Castration Resistant Prostate Cancer (mCRPC) - MAESTRO
NCT02752204An Evaluation AZD2014 Alone and in Combination With Rituximab in Relapsed/Refractory Diffuse Large B Cell Lymphoma
NCT04870580[18F] FDOPA PET Imaging in Glioma: Feasibility Study for PET Guided Brain Biopsy
NCT01719835CHOP vs GEM-P in 1st Line Treatment of T-cell Lymphoma, Multicentre Phase II Study
NCT03424668The European Prospective Investigation Into Cancer in Norfolk Prospective Population Study
NCT05615818Personalized Medicine for Advanced Biliary Cancer Patients
NCT00664781Rucaparib(CO-338;Formally Called AG-014699 or PF-0136738) in Treating Patients With Locally Advanced or Metastatic Breast Cancer or Advanced Ovarian Cancer
NCT00003969Geldanamycin Analogue in Treating Patients With Advanced Cancer
NCT06045910A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies
NCT03028766WEE1 Inhibitor with Cisplatin and Radiotherapy: a Trial in Head and Neck Cancer
NCT05613023A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT
NCT01331525The Addition of Ipilimumab to Carboplatin and Etoposide Chemotherapy for Extensive Stage Small Cell Lung Cancer
NCT00755885Abiraterone Acetate in Treating Postmenopausal Women With Advanced or Metastatic Breast Cancer
NCT05082259ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab
NCT00006476Suramin in Treating Patients With Recurrent Bladder Cancer
NCT0010489717-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Malignant Melanoma
NCT05038657Atezolizumab Immunotherapy, in Immunotherapy Naive Patients With Urinary Tract Squamous Cell Carcinoma (UTSCC).
NCT05770544DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers.
NCT05537844Longitudinal Sample Collection to Investigate Adaptation and Evolution of Ovarian High-grade Serous Carcinoma
NCT06380816A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer
NCT02724163International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia
NCT01598792Safety Study of Recombinant Listeria Monocytogenes(Lm)Based Vaccine Virus Vaccine to Treat Oropharyngeal Cancer
NCT01266486Effect of Metformin on Breast Cancer Metabolism
NCT05722886DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial) - Master Screening Protocol
NCT05991388A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
NCT00554775WBRT & Erlotinib in Advanced NSCLC and Brain Metastases
NCT02688257Assessing Treatment Response in Breast Cancer With Functional Imaging
NCT01793636A Study Comparing AZD2014 vs Everolimus in Patients With Metastatic Renal Cancer
NCT02866370Study Of Nintedanib Compared To Chemotherapy in Patients With Recurrent Clear Cell Carcinoma Of The Ovary Or Endometrium
NCT066302605G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours
NCT00006479Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
NCT02043899A Phase I/II Study of [124I]mIBG PET/CT in Neuroblastoma
NCT00863733Study of DMXAA (Now Known as ASA404) in Solid Tumors
NCT04523116Validation of Tie2 as the First Tumour Vascular Response Biomarker for VEGF Inhibitors: VALTIVE1
NCT00058032CA125 and Ultrasound in Detecting Ovarian Cancer in Postmenopausal Women
NCT03307746A Combination of Rituximab and Varlilumab Immunotherapy in Patients with B-cell Lymphoma
NCT00082927Single-Dose Local Radiation Therapy Compared With Ibandronate in Treating Patients With Localized Metastatic Bone Pain
NCT01413490Hepatitis C Rimantadine and Antiviral Combination Therapy